Mariska Hargitay Partners with Bristol Myers Squibb for “Investigating Myeloma” Awareness Campaign to Honor Her Father 20 Years After Losing Him to the Disease Bristol Myers Squibb
Reflecting on CAR T for First Relapse in Multiple Myeloma Targeted Oncology
5 Tips for Living Well With Multiple Myeloma Everyday Health
Teclistamab in Previously Treated Multiple Myeloma The ASCO Post
Subcutaneous Isatuximab Earns EU Approval in Multiple Myeloma CancerNetwork
Subcutaneous Isatuximab Administered Via OBI Approved in EU for Multiple Myeloma OncLive
Mary Steinbach, DNP, APRN, on Measuring Treatment Response in Multiple Myeloma Cancer Nursing Today
Vij named inaugural Jeffrey S. and Prue H. Gershman Distinguished Professor WashU
‘Law & Order’ star Mariska Hargitay teams up with BMS to investigate multiple myeloma research in awareness campaign Fierce Pharma
The BioPharm Brief: Myeloma, Hemophilia, and KRAS BioPharm International
Equal Access to Modern Therapy May Help Eliminate Survival Differences in Multiple Myeloma Cleveland Clinic
Muhammad Bilal Abid: Balancing Accessibility and Cost-Efficiency in Multiple Myeloma Treatment Oncodaily
Mariska Hargitay investigates multiple myeloma research in BMS awareness campaign Medical Marketing and Media
Striving for a cure for multiple myeloma: What HCPs need to know Johnson & Johnson
Sanofi Wins EU Nod for Subcutaneous Sarclisa in Multiple Myeloma Zacks Investment Research
Machine Learning Model Outperforms Standard Risk Tools for Multiple Myeloma Cleveland Clinic
Mary Steinbach, DNP, APRN, on Supporting Shared Decision-Making in Multiple Myeloma Care Cancer Nursing Today
An Early Look at EHA 2026: 10 Key Studies Heading to Stockholm Targeted Oncology
Bispecific-Based Approaches Highlight Key Multiple Myeloma Data Set to Emerge at EHA 2026 OncLive
Hematologists Highlight Top Data From ASCO 2026 OncLive
Rewriting the Rules on Multiple Myeloma Resistance: Ajai Chari, MD AJMC
Finding a Financial Lifeline During Cancer Cancer Health
Mariska Hargitay Talks Broadway Debut, Knicks, Multiple Myeloma TODAY.com
BCMA CAR T-Cell Therapy Improves OS Vs Teclistamab in Multiple Myeloma CancerNetwork
The blood cancer that became solvable Works in Progress Magazine
Teclistamab Improves Outcomes in Relapsed Multiple Myeloma University of Miami
Pharmacological targeting of IRF4 as a therapeutic strategy for multiple myeloma Nature
Mariska Hargitay Talks Broadway Debut, Knicks, Multiple Myeloma Yahoo
Charting Progress, Changing Outcomes: The Evolution of Multiple Myeloma Care Sanofi
Regina L. Covert Evans: Walking in Faith Through Multiple Myeloma Fox Chase Cancer Center
A new immune strategy to keep multiple myeloma at bay Fred Hutchinson Cancer Center
What You Should Know About Smoldering Multiple Myeloma Health: Trusted and Empathetic Health and Wellness Information
Mariska Hargitay Honors Dad Mickey In Bristol Myers' Myeloma Campaign 06/08/2026 MediaPost
Improving how multiple myeloma is understood and treated Mayo Clinic News Network
Al-Ola Abdallah: Simple Comparison of Teclistamab in Relapsed Multiple Myeloma Across Treatment Settings Oncodaily
Defining cure for multiple myeloma: Lu Anna’s story Roswell Park Comprehensive Cancer Center
Linvoseltamab May Improve Outcomes Vs Teclistamab in R/R Multiple Myeloma CancerNetwork
Multiple Myeloma: Diagnosis and Treatment American Academy of Family Physicians | AAFP
Multiple Myeloma: Improved Prognosis With the Latest Treatments Memorial Sloan Kettering Cancer Center
Edward Cliff: Does Cilta-Cel Have a Future in Myeloma? Oncodaily